Gerald T Keusch

Title: **Gerald T. Keusch: A Contributor to Medical Innovations**

Introduction

Gerald T. Keusch is a notable inventor based in Lexington, MA, who has significantly contributed to the field of medical sciences. With a portfolio of four patents, his work primarily focuses on the development of diagnostic and therapeutic approaches related to infectious diseases.

Latest Patents

Among his latest innovations is the patent for "GP40 and uses thereof," which relates to a gene encoding a novel protein, gp40. This invention highlights the role of gp40 polypeptides in mediating host-parasite interactions. The patent describes isolated and antisense nucleic acid molecules, recombinant expression vectors, and host cells, along with diagnostic, screening, and therapeutic methods utilizing these compositions.

Another significant patent is for "Assays for Shiga toxin and Shiga-like toxins." This invention details a substantially pure antigenic peptide or protein related to Shiga toxin and Shiga-like toxins. It includes a vaccine formulation useful in treating diseases associated with these toxins, as well as methods for detecting and removing Shiga toxins or Shiga-like toxins from biological samples.

Career Highlights

Gerald has been affiliated with leading institutions such as New England Medical Center Hospitals and Tufts College, where he has furthered his research and development initiatives. His innovative work has earned him recognition in the scientific community.

Collaborations

Throughout his career, Gerald has collaborated with distinguished professionals, including David W. Acheson and Arthur Donohue-Rolfe. These partnerships have contributed to the advancement of his research and the impact of his inventions in medical science.

Conclusion

Gerald T. Keusch's contributions to the medical field through his patents exemplify the importance of innovation in addressing health challenges. His work remains a vital part of ongoing research and development in combating infectious diseases.